{"id":"https://openalex.org/W4385380406","doi":"https://doi.org/10.4155/bio-2023-0081","title":"Phage-Derived Anti-Idiotype and Anti-YTE Antibodies in Development of MK-1654 Pharmacokinetic and Immune Response Assays","display_name":"Phage-Derived Anti-Idiotype and Anti-YTE Antibodies in Development of MK-1654 Pharmacokinetic and Immune Response Assays","publication_year":2023,"publication_date":"2023-07-29","ids":{"openalex":"https://openalex.org/W4385380406","doi":"https://doi.org/10.4155/bio-2023-0081","pmid":"https://pubmed.ncbi.nlm.nih.gov/37515532"},"language":"en","primary_location":{"id":"doi:10.4155/bio-2023-0081","doi":"https://doi.org/10.4155/bio-2023-0081","is_oa":false,"landing_page_url":"http://dx.doi.org/10.4155/bio-2023-0081","pdf_url":null,"source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005957235","display_name":"April Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"April Li","raw_affiliation_strings":["PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113547593","display_name":"Michael D. Swanson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Swanson","raw_affiliation_strings":["Current address: Janssen Pharmaceutical, Ambler, PA19002, USA","PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","Current address: Janssen Pharmaceutical, Ambler, PA 19002, USA; PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Current address: Janssen Pharmaceutical, Ambler, PA19002, USA","institution_ids":[]},{"raw_affiliation_string":"PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Current address: Janssen Pharmaceutical, Ambler, PA 19002, USA; PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005980025","display_name":"Nicole Sullivan","orcid":"https://orcid.org/0000-0002-2532-9692","observed_orcids":["https://orcid.org/0000-0002-2532-9692"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Sullivan","raw_affiliation_strings":["Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063185804","display_name":"Ying Homan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Homan","raw_affiliation_strings":["PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052305683","display_name":"Debbie D. Nahas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debbie Nahas","raw_affiliation_strings":["Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090867086","display_name":"Shreya Mukhopadhyay","orcid":"https://orcid.org/0000-0002-2419-1409","observed_orcids":["https://orcid.org/0000-0002-2419-1409"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shreya Mukhopadhyay","raw_affiliation_strings":["Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112934396","display_name":"Hualin Helen Li","orcid":"https://orcid.org/0000-0002-4896-0727","observed_orcids":["https://orcid.org/0000-0002-4896-0727"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hualin Helen Li","raw_affiliation_strings":["Analytical Research and Development, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Research and Development, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039275027","display_name":"Yu Cao","orcid":"https://orcid.org/0000-0003-3471-1719","observed_orcids":["https://orcid.org/0000-0003-3471-1719"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Cao","raw_affiliation_strings":["PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017677021","display_name":"Weifeng Xu","orcid":"https://orcid.org/0000-0001-7598-1489","observed_orcids":["https://orcid.org/0000-0001-7598-1489","https://orcid.org/0009-0004-9920-2864"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weifeng Xu","raw_affiliation_strings":["PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101667885","display_name":"Huaping Tang","orcid":"https://orcid.org/0009-0005-3801-420X","observed_orcids":["https://orcid.org/0009-0005-3801-420X","https://orcid.org/0000-0002-2464-5028"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Huaping Tang","raw_affiliation_strings":["Current address: GSK Pharmaceutical, Collegeville, PA19426, USA","PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","Current address: GSK Pharmaceutical, Collegeville, PA 19426, USA; PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Current address: GSK Pharmaceutical, Collegeville, PA19426, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Current address: GSK Pharmaceutical, Collegeville, PA 19426, USA; PCD Regulated Immunogenicity and Molecular, Merck and Co., Inc., West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048700949","display_name":"Kalpit A. Vora","orcid":"https://orcid.org/0000-0001-9844-634X","observed_orcids":["https://orcid.org/0000-0001-9844-634X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kalpit A Vora","raw_affiliation_strings":["Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100715426","display_name":"Zhifeng Chen","orcid":"https://orcid.org/0000-0002-9390-6527","observed_orcids":["https://orcid.org/0000-0002-9390-6527"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhifeng Chen","raw_affiliation_strings":["Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA"],"raw_orcid":"https://orcid.org/0000-0002-9390-6527","affiliations":[{"raw_affiliation_string":"Infectious Diseases and Vaccine Research, Merck and Co., Inc., West Point, PA19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5048700949"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":null,"apc_paid":null,"fwci":0.3297,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.52006627,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"15","issue":"16","first_page":"1049","last_page":"1067"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8438000082969666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.1477999985218048,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-idiotypic-antibodies","display_name":"anti-idiotypic antibodies","score":0.9070000052452087},{"id":"https://openalex.org/keywords/phage-display","display_name":"phage display","score":0.7020000219345093},{"id":"https://openalex.org/keywords/rsv-prophylaxis","display_name":"RSV prophylaxis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/neutralizing-antibody-assay","display_name":"neutralizing antibody assay","score":0.7480000257492065},{"id":"https://openalex.org/keywords/positive-control","display_name":"positive control","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7436387538909912},{"id":"https://openalex.org/C74505204","wikidata":"https://www.wikidata.org/wiki/Q1047644","display_name":"Idiotype","level":4,"score":0.7328301668167114},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6491608023643494},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6249638795852661},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5186761617660522},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.450308620929718},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42170625925064087},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29868030548095703},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24941971898078918}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001435","descriptor_name":"Bacteriophages","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007109","descriptor_name":"Immunity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4155/bio-2023-0081","doi":"https://doi.org/10.4155/bio-2023-0081","is_oa":false,"landing_page_url":"http://dx.doi.org/10.4155/bio-2023-0081","pdf_url":null,"source":{"id":"https://openalex.org/S159955403","display_name":"Bioanalysis","issn_l":"1757-6180","issn":["1757-6180","1757-6199"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"journal-article"},{"id":"pmid:37515532","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37515532","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioanalysis","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1545375457","https://openalex.org/W1965170475","https://openalex.org/W1979767710","https://openalex.org/W1986189079","https://openalex.org/W1989501142","https://openalex.org/W1993045767","https://openalex.org/W1996756490","https://openalex.org/W2004755769","https://openalex.org/W2014452171","https://openalex.org/W2018717876","https://openalex.org/W2030522563","https://openalex.org/W2038994620","https://openalex.org/W2041676832","https://openalex.org/W2061478440","https://openalex.org/W2070360032","https://openalex.org/W2071378581","https://openalex.org/W2085175978","https://openalex.org/W2085577978","https://openalex.org/W2107671223","https://openalex.org/W2123337975","https://openalex.org/W2144886557","https://openalex.org/W2181230016","https://openalex.org/W2415131859","https://openalex.org/W2604669216","https://openalex.org/W2619867514","https://openalex.org/W2811073505","https://openalex.org/W2885098730","https://openalex.org/W2926566926","https://openalex.org/W2972594574","https://openalex.org/W3092622934","https://openalex.org/W3092715783","https://openalex.org/W3097935535","https://openalex.org/W3136815103","https://openalex.org/W3211514846","https://openalex.org/W4205628911","https://openalex.org/W4225368692","https://openalex.org/W4297210376"],"related_works":["https://openalex.org/W2014452171","https://openalex.org/W2021735949","https://openalex.org/W2061478440","https://openalex.org/W7131875926","https://openalex.org/W2915518081","https://openalex.org/W2004755769","https://openalex.org/W2070889895","https://openalex.org/W2215159685","https://openalex.org/W2902085268","https://openalex.org/W3143413754"],"abstract_inverted_index":{"Background:":[0],"MK-1654":[1,40,56,67],"is":[2],"a":[3],"fully":[4],"human":[5,24,72],"monoclonal":[6],"antibody":[7,105],"with":[8,43],"YTE":[9],"mutations":[10],"currently":[11],"in":[12,20,52,68,90,103],"phase":[13],"III":[14],"clinical":[15],"trials":[16],"for":[17,114],"prophylactic":[18],"use":[19,78],"protecting":[21],"infants":[22],"from":[23],"respiratory":[25],"syncytial":[26],"virus":[27],"infection.":[28],"Materials":[29],"&":[30],"methods:":[31],"We":[32],"generated":[33],"anti-idiotype":[34],"(anti-ID)":[35],"and":[36,48,59,71,81,88,110,116],"anti-YTE":[37,82],"antibodies":[38,51,83],"against":[39],"by":[41],"panning":[42],"MorphoSys":[44],"HuCal":[45],"phage":[46],"libraries,":[47],"used":[49],"the":[50,53],"development":[54],"of":[55,66,79],"pharmacokinetic":[57],"(PK)":[58],"immune":[60],"response":[61],"(IR)":[62],"assays.":[63,106,118],"Results:":[64],"Detection":[65],"nonhuman":[69],"primate":[70],"nasal":[73],"wash":[74],"samples":[75],"showed":[76,95],"combined":[77],"anti-ID":[80,96],"can":[84,97],"deliver":[85],"desired":[86],"sensitivity":[87],"accuracy":[89],"PK":[91,115],"studies.":[92],"IR":[93,117],"studies":[94],"serve":[98],"as":[99],"suitable":[100,113],"positive":[101],"control":[102],"neutralizing":[104],"Conclusion:":[107],"Phage-derived":[108],"anti-IDs":[109],"anti-YTEs":[111],"are":[112]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-07-30T00:00:00"}